Andrew McKeegan
SVP of Strategy, Finance, and Investor Relations
Replay available
Mirum Pharmaceuticals, Inc. (MIRM) Q2 2025 Earnings Call
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) Q2 2025 earnings conference call, held 2025-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Chris Peets
Chief Executive Officer
Peter Radovich
President and Chief Operating Officer
Joanne Kwan
Chief Medical Officer
Eric Bjerkel
Chief Financial Officer
Gavin Clarkartner
Analyst (Evercore)
Ryan Dashner
Analyst (Raymond James)
Mike Oles
Analyst (Morgan Stanley)
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Mirum Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.537 -- 00:00:05.143 Hello, everyone, and welcome to the Neuron Pharmaceuticals Report Second Quarter 2025 00:00:05.143 -- 00:00:09.047 Financial Results and Provide Business Update. 00:00:09.047 -- 00:00:11.610 My name is Carla, and I will be coordinating your call today. 00:00:11.610 -- 00:00:15.716 During the presentation, you can register to ask questions by pressing star followed 00:00:15.716 -- 00:00:19.720 by 1 on your telephone keypad. If you change your mind, please press star followed by 00:00:19.720 -- 00:00:24.706 2. I would now like to hand you over to your host, Andrew McKeegan, 00:00:24.706 -- 00:00:29.438 SVP of Strategies strategic, finance, and investor relations to begin. 00:00:29.438 -- 00:00:32.380 Please go ahead when you're ready. 00:00:32.623 -- 00:00:35.086 Thanks, Carla, and good afternoon, everyone. 00:00:35.086 -- 00:00:39.513 I'd like to welcome you to Miriam Pharmaceutical's second quarter 2025 conference call. 00:00:39.513 -- 00:00:43.779 I'm joined today by our CEO, Chris Peets, our President and Chief Operating Officer, 00:00:43.779 -- 00:00:48.365 Peter Radovich, our Chief Medical Officer, Joanne Kwan, and Eric Bjerkel, our Chief Financial 00:00:48.365 -- 00:00:52.351 Officer. Earlier today, Miriam issued a news release announcing the company's results 00:00:52.351 -- 00:00:57.028 for the second quarter 2025. Copies of this news release and SEC filings can be found 00:00:57.028 -- 00:01:01.033 in the Investors section of our website. Before we start, I'd like to remind you that 00:01:01.033 -- 00:01:04.798 during the course of this conference call, we'll be making certain forward-looking statements 00:01:04.798 -- 00:01:09.003 based on management's current expectations, including statements regarding Merrim's programs ...